Effect of Vatakarma Kapalbhati on Sinus Headache
Journal of Primary Care Specialties · 2023
DOI: 10.4103/jopcs.jopcs_15_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care Specialties, 2023. Verfasst von Poornima Ravi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Sinusitis is a common inflammatory condition affecting paranasal sinuses encountered by people of all age groups. Vatakarma Kapalbhati is a yogic cleansing technique and pranayama found to be beneficial in sinus headaches. We reported the effect of Vatakarma Kapalbhati on three individual cases with sinus headaches. Three women who had chronic headaches due to paranasal sinusitis were given Vatakarma Kapalbhati as an intervention. Outcome measures such as Pittsburgh Sleep Quality Index (PSQI), Sinonasal Outcome Test-22 (SNOT-22), Headache Impact Test-6 (HIT-6), and Visual Analog Scale (VAS) were used to assess the efficacy of the intervention. Significant improvement in PSQI, SNOT-22, HIT-6, and VAS was found postintervention when compared to the baseline. Vatakarma Kapalbhati could be a potential supportive therapy for the management of sinusitis headaches alongside conventional management.
Zitieren
APA
Ravi, P., Venugopal, V., Boopalan, D., Anandhan, A., Chidambaram, Y., & Kuppusamy, M. (2023). Effect of Vatakarma Kapalbhati on Sinus Headache. Journal of Primary Care Specialties. https://doi.org/10.4103/jopcs.jopcs_15_22
Vancouver
Ravi P, Venugopal V, Boopalan D, Anandhan A, Chidambaram Y, Kuppusamy M. Effect of Vatakarma Kapalbhati on Sinus Headache. Journal of Primary Care Specialties. 2023. doi:10.4103/jopcs.jopcs_15_22
BibTeX
@article{Ravi2023,
author = {Ravi, Poornima and Venugopal, V and Boopalan, Deenadayalan and Anandhan, Akila and Chidambaram, Yogapriya and Kuppusamy, Maheshkumar},
title = {Effect of Vatakarma Kapalbhati on Sinus Headache},
journal = {Journal of Primary Care Specialties},
year = {2023},
doi = {10.4103/jopcs.jopcs_15_22}
}
EUVIMED